Daniel D. Long, SVP, Drug Discovery at Septerna, Inc. (SEPN), sold 7,002 shares at $18.06 ($126K) on 2025-11-10, disclosed to the SEC on 2025-11-13.
Open-market sale of $126k SEPN by SVP, Drug Discovery. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.06 | 3,501 | $63K | 50.0% |
| 2 | $18.06 | 3,501 | $63K | 50.0% |
| Total | $18.06 avg | 7,002 | $126K | 100% |
| Filing → |
| SEPN | SELL | 2026-07-02 | $115K | — | Filing → |
| SEPN | SELL | 2026-06-24 | $533K | — | Filing → |